Corrigendum: Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury

Xinzhu Zhang; Wu Xiong; Guang Kong; Yushan Zhen; Qiang Zeng; Siming Wang; Sheng Chen; Jun Gu; Cong Li; Kaijin Guo

doi:10.3389/fphar.2024.1451951

Corrigendum: Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury

Front Pharmacol. 2024 Aug 1:15:1451951. doi: 10.3389/fphar.2024.1451951. eCollection 2024.

Authors

Xinzhu Zhang^#^{1

2}, Wu Xiong^#^{1

3}, Guang Kong^#^{1

4

5}, Yushan Zhen^#⁶, Qiang Zeng^#¹, Siming Wang^{1

3}, Sheng Chen⁵, Jun Gu⁷, Cong Li^{1

3}, Kaijin Guo^{1

2}

Affiliations

¹ Nanjing Medical University, Nanjing, China.
² Department of Orthopedics, The First Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
³ Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
⁴ Gusu School, Nanjing Medical University, Suzhou, China.
⁵ Department of Orthopedics, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou, China.
⁶ Medical College of Jiangsu University, Zhenjiang, China.
⁷ Department of Orthopedics, Xishan People's Hospital, Wuxi, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.957433.].

Keywords: chondroitin sulfate proteoglycan inhibition; paclitaxel; spermine-functionalized acetalated dextran; spinal cord injury.

Publication types

Published Erratum